Esophageal stricture medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
Main stay of treatment of esophageal stricture is dilatation.
Supportive medical therapy for esophageal stricture secondary to Gastroesophageal reflux disease includes proton pump inhibitors.
Proton pump inhibitors also help in prevention of recurrence after surgical esophageal dilatation.
20 mg twice daily is the standard therapy for most of the patients following dilatation. Patients who do not respond to the standard dose me require increased dose of 40 mg twice daily.
Proton pump inhibitors have been found more effective in acid suppression in these patients as compared to H2 blockers.
__NOTOC__
__NOTOC__
{{Esophageal stricture}}
{{Esophageal stricture}}
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 
====Contraindicated medications====
{{MedCondContrAbs|MedCond = Esophageal stricture|Alendronate|Ibandronic acid}}
{{MedCondContrAbs|MedCond = Esophageal stricture|Alendronate|Ibandronic acid}}


==References==
==References==
{{reflist|2}}
https://www.ncbi.nlm.nih.gov/pubmed?term=7848395<nowiki/>{{reflist|2}}
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Needs content]]
[[Category:Needs content]]

Revision as of 03:32, 16 October 2017

Main stay of treatment of esophageal stricture is dilatation.

Supportive medical therapy for esophageal stricture secondary to Gastroesophageal reflux disease includes proton pump inhibitors.

Proton pump inhibitors also help in prevention of recurrence after surgical esophageal dilatation.

20 mg twice daily is the standard therapy for most of the patients following dilatation. Patients who do not respond to the standard dose me require increased dose of 40 mg twice daily.

Proton pump inhibitors have been found more effective in acid suppression in these patients as compared to H2 blockers.


Esophageal stricture Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esophageal stricture from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Procedure
Surgical Management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal stricture medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal stricture medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal stricture medical therapy

CDC on Esophageal stricture medical therapy

Esophageal stricture medical therapy in the news

Blogs on Esophageal stricture medical therapy

Directions to Hospitals Treating Esophageal stricture

Risk calculators and risk factors for Esophageal stricture medical therapy


Esophageal stricture is considered an absolute contraindication to the use of the following medications:

References

https://www.ncbi.nlm.nih.gov/pubmed?term=7848395

Template:WH Template:WS